Scientific
MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis
These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.
MK5 Proteome Analysis

Table 3: Type II network, divided ranks. This table presents the output of the simulation of a type-II network in which we relied on the high confidence interactions and micro-array results. The output of the micro-array was then ranked and these ranks used as input into the network simulation. After performing two such simulations (one for the MK5 off and one for the MK5 on microarray output), we divided the ranks and sorted the results accordingly. The output of this technique is a collection of proteins that cluster naturally together.
Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Rank Gene Hugo description Value Type Network Comparison Type Interaction Map Filtered red green network_comparison
Results: HTML CSV LaTeX
Showing element 1658 to 1707 of 3228 in total
Value Type: Ranked
Network Comparison Type: Divided
Interaction Map: High confidence
Filtered: 1

\def\wcA{0.14285714285714\textwidth}
\def\wcB{0.14285714285714\textwidth}
\def\wcC{0.14285714285714\textwidth}
\def\wcD{0.14285714285714\textwidth}
\def\wcE{0.14285714285714\textwidth}
\def\wcF{0.14285714285714\textwidth}
\begin{longtable}{|c|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
Hugo\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
red\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
green\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
network\_comparison\vspace{3pt}}\\
\hline
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1658\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ATP5A1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
atp synthase alpha chain, mitochondrial precursor (ec 3.6.3.14). [source:swissprot;acc:p25705]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
217.925\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
214.826\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.01443\vspace{3pt}}}\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
1659\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
MRPS18A\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
28s ribosomal protein s18a, mitochondrial precursor (mrp-s18-a) (mrps18a) (mrp-s18-3). [source:swissprot;acc:q9nvs2]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1660\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
EEA1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
early endosome antigen 1, 162kd; early endosome-associated protein. [source:refseq;acc:nm\_003566]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
228.654\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
231.933\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.01434\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1661\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ADSSL1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
adenylosuccinate synthase-like 1. [source:refseq;acc:nm\_152328]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
204.437\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
201.551\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.01432\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1662\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
MORF4L2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
transcription factor-like protein mrgx (morf-related gene x protein) (mortality factor 4-like 2) (msl3-2 protein). [source:swissprot;acc:q15014]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
228.477\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
231.747\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.01431\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1663\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
TDO2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
tryptophan 2,3-dioxygenase (ec 1.13.11.11) (tryptophan pyrrolase) (tryptophanase) (tryptophan oxygenase) (tryptamin 2,3-dioxygenase) (trpo). [source:swissprot;acc:p48775]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
218.335\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
215.26\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.01429\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1664\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
transcription factor-like protein morf4 (mortality factor 4) (cellular senescence-related protein 1) (sen1). [source:swissprot;acc:q9y690]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
228.484\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
231.74\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.01425\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1665\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ADSS\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
adenylosuccinate synthetase (ec 6.3.4.4) (imp--aspartate ligase) (adss) (ampsase). [source:swissprot;acc:p30520]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
204.433\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
201.564\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.01423\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1666\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
TNPO2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
karyopherin beta 2b, transportin; importin 3. [source:refseq;acc:nm\_013433]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
218.679\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
215.612\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.01422\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1667\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
CTSB\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
cathepsin b precursor (ec 3.4.22.1) (cathepsin b1) (app secretase). [source:swissprot;acc:p07858]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
214.898\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
211.898\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.01416\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1668\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}}&\parbox{\wcC}{\vspace{3pt}\noindent
survival motor neuron protein (component of gems 1) (gemin1). [source:swissprot;acc:q16637]\vspace{3pt}}&\multirow{8}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
228.496\vspace{3pt}}}&\multirow{8}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
231.729\vspace{3pt}}}&\multirow{8}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.01415\vspace{3pt}}}\\\cline{1-1}\cline{3-3}
\parbox{\wcA}{\vspace{3pt}\noindent
1669\vspace{3pt}}&&\parbox{\wcC}{\vspace{3pt}\noindent
ras-related c3 botulinum toxin substrate 1 (p21-rac1) (ras-like protein tc25). [source:swissprot;acc:p15154]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
1670\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
RAC3\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
ras-related c3 botulinum toxin substrate 3 (p21-rac3). [source:swissprot;acc:o14658]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
1671\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
NUP54\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
nucleoporin 54kda; nucleoporin p54. [source:refseq;acc:nm\_017426]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
1672\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
RAC2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
ras-related c3 botulinum toxin substrate 2 (p21-rac2) (small g protein) (gx). [source:swissprot;acc:p15153]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
1673\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
MCM5\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
dna replication licensing factor mcm5 (cdc46 homolog) (p1-cdc46). [source:swissprot;acc:p33992]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
1674\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
SIP1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
survival of motor neuron protein-interacting protein 1 (smn- interacting protein 1) (component of gems 2) (gemin2). [source:swissprot;acc:o14893]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
1675\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
DDX20\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
probable atp-dependent rna helicase ddx20 (dead-box protein 20) (dead- box protein dp 103) (component of gems 3) (gemin3). [source:swissprot;acc:q9uhi6]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1676\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
TNPO1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
importin beta-2 subunit (karyopherin beta-2 subunit) (transportin) (m9 region interaction protein) (mip). [source:swissprot;acc:q92973]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
218.691\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
215.645\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.01413\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1677\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
GSTP1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
glutathione s-transferase p (ec 2.5.1.18) (gst class-pi) (gstp1-1). [source:swissprot;acc:p09211]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
218.654\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
221.732\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.01408\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1678\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
SRPK3\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
serine/threonine protein kinase 23 (ec 2.7.1.37) (muscle-specific serine kinase 1) (mssk-1). [source:swissprot;acc:q9upe1]\vspace{3pt}}&\multirow{8}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
216.899\vspace{3pt}}}&\multirow{8}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
213.889\vspace{3pt}}}&\multirow{8}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.01407\vspace{3pt}}}\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
1679\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
GTPBP2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
gtp binding protein 2. [source:refseq;acc:nm\_019096]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
1680\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
CREBL1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
cyclic-amp-dependent transcription factor atf-6 beta (activating transcription factor 6 beta) (atf6-beta) (camp responsive element binding protein-like 1) (camp response element binding protein-related protein) (creb-rp) (g13 protein). [source:swissprot;acc:q99941]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
1681\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
FAM50B\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
dna segment on chromosome 6(unique) 2654 expressed sequence; dna segment on chromosome x (unique) 2654 expressed sequence. [source:refseq;acc:nm\_012135]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
1682\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
SRPK2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
sfrs protein kinase 2 isoform b. [source:refseq;acc:nm\_182691]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
1683\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ATF6\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
cyclic-amp-dependent transcription factor atf-6 alpha (activating transcription factor 6 alpha) (atf6-alpha). [source:swissprot;acc:p18850]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
1684\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
SRPK1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
sfrs protein kinase 1; sr protein kinase 1. [source:refseq;acc:nm\_003137]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
1685\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
FAM50A\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
xap-5 protein (hxc-26 protein). [source:swissprot;acc:q14320]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1686\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
OSGEPL1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
putative sialoglycoprotease type 2. [source:refseq;acc:nm\_022353]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
220.75\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
217.704\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.01399\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1687\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ATP5D\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
atp synthase delta chain, mitochondrial precursor (ec 3.6.3.14). [source:swissprot;acc:p30049]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
215.345\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
212.386\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.01393\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1688\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
MORF4L1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
transcription factor-like protein mrg15 (morf-related gene 15 protein) (mortality factor 4-like 1) (msl3-1 protein) (hspc008/hspc061). [source:swissprot;acc:q9ubu8]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
228.523\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
231.703\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.01392\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1689\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
DDX4\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
dead-box protein 4 (vasa homolog). [source:swissprot;acc:q9nqi0]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
228.277\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
225.163\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.01383\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1690\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
RPS24\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
40s ribosomal protein s24 (s19). [source:swissprot;acc:p16632]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
224.091\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
227.184\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.0138\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1691\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
EIF5B\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
translation initiation factor if-2. [source:swissprot;acc:o60841]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
217.263\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
214.315\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.01376\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1692\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
RBM9\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
rna-binding protein 9 (rna binding motif protein 9) (hexaribonucleotide binding protein 2) (repressor of tamoxifen transcriptional activity). [source:swissprot;acc:o43251]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
218.515\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
215.551\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.01375\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1693\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
IMPDH2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
inosine-5'-monophosphate dehydrogenase 2 (ec 1.1.1.205) (imp dehydrogenase 2) (impdh-ii) (impd 2). [source:swissprot;acc:p12268]\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
218.937\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
215.971\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.01373\vspace{3pt}}}\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
1694\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
GMPS\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
gmp synthase [glutamine-hydrolyzing] (ec 6.3.5.2) (glutamine amidotransferase) (gmp synthetase). [source:swissprot;acc:p49915]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
1695\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
IMPDH1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
inosine-5'-monophosphate dehydrogenase 1 (ec 1.1.1.205) (imp dehydrogenase 1) (impdh-i) (impd 1). [source:swissprot;acc:p20839]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1696\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
PABPC3\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
polyadenylate-binding protein 3 (poly(a)-binding protein 3) (pabp 3) (testis-specific poly(a)-binding protein). [source:swissprot;acc:q9h361]\vspace{3pt}}&\multirow{5}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
217.624\vspace{3pt}}}&\multirow{5}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
214.69\vspace{3pt}}}&\multirow{5}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.01367\vspace{3pt}}}\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
1697\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
KIN\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
hskin17 protein. [source:refseq;acc:nm\_012311]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
1698\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
CRAT\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
carnitine o-acetyltransferase (ec 2.3.1.7) (carnitine acetylase) (cat). [source:swissprot;acc:p43155]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
1699\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
PABPC4\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
polyadenylate-binding protein 4 (poly(a)-binding protein 4) (pabp 4) (inducible poly(a)-binding protein) (ipabp) (activated-platelet protein-1) (app-1). [source:swissprot;acc:q13310]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
1700\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
PABPC1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
polyadenylate-binding protein 1 (poly(a)-binding protein 1) (pabp 1). [source:swissprot;acc:p11940]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1701\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
G6PD\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
glucose-6-phosphate 1-dehydrogenase (ec 1.1.1.49) (g6pd). [source:swissprot;acc:p11413]\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
216.079\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
219.024\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.01363\vspace{3pt}}}\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
1702\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
XRCC3\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
dna-repair protein xrcc3 (x-ray repair cross-complementing protein 3). [source:swissprot;acc:o43542]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
1703\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
RECQL5\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
atp-dependent dna helicase q5 (recq protein-like 5) (recq5). [source:swissprot;acc:o94762]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1704\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
ataxin 2-binding protein. [source:swissprot;acc:q9nwb1]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
218.514\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
215.577\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.01362\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1705\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
PPP4C\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
serine/threonine protein phosphatase 4 (ec 3.1.3.16) (pp4) (protein phosphatase x) (pp-x). [source:swissprot;acc:p33172]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
223.846\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
220.847\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.01358\vspace{3pt}}}\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
1706\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
IGBP1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
immunoglobulin-binding protein 1 (cd79a-binding protein 1) (b cell signal transduction molecule alpha 4) (alpha 4 protein). [source:swissprot;acc:p78318]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1707\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
BUB1B\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
mitotic checkpoint serine/threonine-protein kinase bub1 beta (ec 2.7.1.-) (hbubr1) (mad3/bub1-related protein kinase) (mitotic checkpoint kinase mad3l). [source:swissprot;acc:o60566]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
221.283\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
218.334\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.01351\vspace{3pt}}\\\hline
nd{longtable}

Legend:
- Rank is the rank after comparing the two networks

 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray

 - Hugo is the HGNC identifier if it exists

 - Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.

 - Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them

 - Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.

 - Filtered specifies whether we only included the high confidence microarry measurements or not.
- http://analysis.yellowcouch.org/